Alzheimer's disease (AD) is a progressive neurodegenerative disease with a few FDA-
approved drugs that provide modest symptomatic benefits and only two FDA-approved …

Toxic aggregated amyloid-β accumulation is a key pathogenic event in Alzheimer's disease.
Treatment approaches have focused on the suppression, deferral, or dispersion of amyloid …

It has been estimated that every year, millions of people are affected by neurodegenerative
disorders, which complicate their lives and their caregivers' lives. To date, there has not …

The blood-brain barrier (BBB) is the most specialized biological barrier in the body. This
configuration of specialized cells protects the brain from invasion of molecules and particles …

Alzheimer's disease (AD) is a chronic progressive neurodegenerative disease that
constitutes the third most common cause of death among elderly individuals. AD patients …

Neurodegenerative diseases (NDs), conventionally characterized by multifarious impacts on
patients' cognitive skill, motor function and memory, have been brought into focus with the …

Neurodegenerative diseases (ND), as a group of central nervous system (CNS) disorders,
are among the most prominent medical problems of the 21 st century. They are often …

Alzheimer's disease is a neurodegenerative disorder that affects elderly, and its incidence is
continuously increasing across the globe. Unfortunately, despite decades of research, a …

The purpose of our current study was to establish a long non-coding RNA (lncRNA)
signature and assess its prognostic and diagnostic power in papillary thyroid cancer (PTC) …

Neurological diseases (NDs) are one of the leading causes of disability and the second
leading cause of death globally. Among these stroke, Alzheimer's disease (AD), and …